Atara Biotherapeutics Inc (ATRA) — Cash Flow Quality Index
Latest as of June 2025:
-3.07x
Atara Biotherapeutics Inc (ATRA) has a Cash Flow Quality Index of -3.07x as of June 2025. Operating cash flow of $-7.32 Million is below net income of $2.39 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Atara Biotherapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-3.07x
Operating CF / Net Income
Operating Cash Flow
$-7.32 Million
USD
Net Income
$2.39 Million
USD
Data as of
Jun 2025
Most recent filing
Annual Cash Flow Quality Index for Atara Biotherapeutics Inc (None–None)
Year-by-year earnings quality comparison for Atara Biotherapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.